Overview

Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis

Status:
Unknown status
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to learn if adding femtosecond laser-assisted corneal debridement to a standard therapy of oral ganciclovir can help shorten the healing time of herpes simplex epithelial keratitis (HSK).
Phase:
N/A
Details
Lead Sponsor:
Chunxiao Wang
Treatments:
Ganciclovir
Ganciclovir triphosphate